BRIEF published on 06/30/2025 at 22:35, 1 year 4 months ago EUROPLASMA Dément les Informations de Boursier.com Europlasma Financement Obligataire Démenti Information Erronée Boursier.com
BRIEF published on 06/30/2025 at 22:35, 1 year 4 months ago EUROPLASMA Denies Information from Boursier.com Europlasma Bond Financing Denial Incorrect Information Boursier.com
BRIEF published on 06/30/2025 at 22:35, 1 year 4 months ago EUROPLASMA dément les fausses informations sur un prétendu financement obligataire Europlasma Financement Obligataire Démenti Manipulation De Cours Information Erronée
BRIEF published on 06/30/2025 at 22:35, 1 year 4 months ago EUROPLASMA denies false information about alleged bond financing Europlasma Bond Financing Denial Course Manipulation Incorrect Information
BRIEF published on 06/30/2025 at 22:35, 1 year 4 months ago Biophytis reporte la publication de ses comptes annuels Biophytis Biotechnologie Comptes Annuels Recherche Clinique Publication Retardée
BRIEF published on 06/30/2025 at 22:35, 1 year 4 months ago Biophytis Delays Publication of 2024 Annual Financial Statements Biophytis Biotechnology Drug Development Annual Accounts Financial Delay
BRIEF published on 06/30/2025 at 22:35, 1 year 4 months ago Les résultats 2024 du Groupe Lucibel marquent une transformation stratégique Restructuration Résultats 2024 Lumière Cosmétique Lucibel Croissance 2025
BRIEF published on 06/30/2025 at 22:35, 1 year 4 months ago Lucibel Group's 2024 results mark a strategic transformation Restructuring Lucibel Cosmetic Light 2024 Results Growth 2025
BRIEF published on 06/30/2025 at 22:10, 1 year 4 months ago Protagonist Therapeutics Introduces PN-477 for Obesity Treatment Obesity Treatment Protagonist Therapeutics PN-477 Triple Agonist Peptide GLP-1, GIP, GCG
BRIEF published on 06/30/2025 at 22:10, 1 year 4 months ago Protagonist Therapeutics présente le PN-477 pour le traitement de l'obésité Traitement De L'obésité Thérapeutique Protagoniste PN-477 GLP-1, GIP, GCG Peptide Triple Agoniste
Published on 11/20/2026 at 15:00, 2 days 9 hours ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 2 days 9 hours ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 2 days 10 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 2 days 10 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 2 days 10 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 22:39, 2 days 1 hour ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 2 days 2 hours ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 2 days 3 hours ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 2 days 5 hours ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 2 days 5 hours ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 2 days 6 hours ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 2 days 6 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 3 days 5 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR